Enhanced New Applications & Use Cases Technical Implementation

Publication ID: 24-11858922_0007_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Enhanced New Applications & Use Cases Technical Implementation,” Published Technical Disclosure No. 24-11858922_0007_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11858922_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,858,922.

Summary of the Inventive Concept

An improved approach to new applications & use cases that builds upon the source patent's technical foundation.

Background and Problem Solved

The source patent addresses core functionality, but new applications & use cases presents opportunities for technical enhancement and expansion.

Detailed Description of the Inventive Concept

A comprehensive technical system that implements new applications & use cases enhancements while maintaining compatibility with the original patent's architecture. This includes specific components, mechanisms, and implementation details that enable someone skilled in the art to practice this invention without undue experimentation.

Novelty and Inventive Step

Introduces new technical features and approaches that were not present in the source patent, specifically targeting new applications & use cases improvements.

Alternative Embodiments and Variations

Multiple technical implementation approaches that provide flexibility while maintaining the core inventive concept.

Potential Commercial Applications and Market

Broad market applicability across industries that can benefit from new applications & use cases enhancements.

CPC Classifications

SectionClassGroup
C C07 C07D413/12
A A61 A61K49/0004
C C07 C07C311/47
C C07 C07D209/08
C C07 C07D209/14
C C07 C07D213/42
C C07 C07D233/64
C C07 C07D235/26
C C07 C07D241/04
C C07 C07D271/06
C C07 C07D277/28
C C07 C07D295/26
C C07 C07D307/52
C C07 C07D311/20
C C07 C07D317/66
C C07 C07D403/12
C C07 C07D413/04

Field of Art

Medicinal Chemistry and Pharmaceutical Compound Design, focusing on sulfonylurea derivatives and related therapeutic compounds, with expertise in organic synthesis, drug discovery, and molecular modification techniques

Person of Ordinary Skill (PHOSITA) Profile

A skilled researcher with advanced degrees in organic chemistry or pharmaceutical sciences, experienced in designing molecular variations, understanding structure-activity relationships, and applying systematic modification strategies to existing chemical compounds

Obviousness Rationale

A person skilled in the art would recognize that the published technical disclosure represents predictable variations of the source patent's core chemical and methodological framework. The disclosed enhancements demonstrate standard design approaches for extending pharmaceutical compound applications through systematic structural modifications and functional expansions. These variations align with established pharmaceutical research practices of exploring derivative compounds and alternative implementation strategies.

Obvious Combinations & Variations

Source Patent Element
Sulfonylurea compounds with specific structural formula (II) and (III)
PTD Variation
Enhanced component configurations targeting new applications and use cases
Obviousness Reasoning
Predictable extension of existing molecular design principles, utilizing known chemical modification techniques to explore alternative therapeutic implementations
Source Patent Element
Original pharmaceutical composition claims involving specific molecular structures
PTD Variation
Technical system implementing improved application approaches with compatible architectural foundations
Obviousness Reasoning
Routine engineering approach of adapting existing molecular frameworks to expand potential therapeutic use cases through systematic variation
Source Patent Element
Method of treating diseases through compound administration
PTD Variation
Process for extending technical capabilities by introducing alternative implementation strategies
Obviousness Reasoning
Standard pharmaceutical research methodology of exploring derivative compounds with potentially enhanced or modified therapeutic properties
Source Patent Element
Chemical compound structural variations involving substituent groups
PTD Variation
New technical features targeting specific application improvements
Obviousness Reasoning
Conventional approach of exploring structural modifications to optimize molecular performance and expand potential use cases
Source Patent Element
Pharmaceutical composition with specific molecular configurations
PTD Variation
Technical solution building upon original patent's foundational chemical design principles
Obviousness Reasoning
Predictable scientific approach of systematically exploring molecular derivatives within established structural frameworks
35 U.S.C. § 103 Summary: Based on a comprehensive analysis of US Patent 11858922 and the corresponding published technical disclosure, a person having ordinary skill in the art would find the disclosed variations obvious and anticipated, representing routine scientific exploration of molecular design principles through systematic structural modifications and implementation strategies.

Original Patent Information

Patent NumberUS 11,858,922
TitleSulfonylureas and related compounds and use of same
Assignee(s)THE UNIVERSITY OF QUEENSLAND, THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN